Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDS01 + Chemotherapy in Advanced Head and Neck Cancer
NCT02283489Phase 2Unknown
- Start
- Oct 2014
- Primary completion
- Oct 2016
- Modality
- Gene Editing, Gene Silencing, Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of Recombinant human endostatin adenovirus in head and neck cancer (HNC). Status: unknown.
02
Drugs
Recombinant human endostatin adenovirus
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT02283489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02283489.